Blood test may predict liver cancer treatment success
NCT ID NCT07414433
First seen Feb 22, 2026 · Last updated May 12, 2026 · Updated 7 times
Summary
This study is testing whether certain substances in the blood can help doctors predict and monitor how well liver cancer responds to a standard treatment called TACE. About 60 adults with liver cancer will give blood samples before and after TACE, and the results will be compared with CT or MRI scans. The goal is to see if blood tests can reliably show early on whether the treatment is working, potentially reducing the need for frequent imaging.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
KBC Bežanijska kosa
Belgrade, Serbia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.